GRDN · Guardian Pharmacy Services Inc. Class A Common Stock
View on chartInsiders & Stakes
| William E. Bindley Director | ▲ Buy | Option Exercise | 16,669,666 Shares held | 9/27/2026 | View profile |
| Bindley Capital Partners I, LLC | ▲ Buy | Option Exercise | 16,669,666 Shares held | 9/27/2026 | View profile |
| Thomas J. Salentine Jr. | ▲ Buy | Option Exercise | 16,669,666 Shares held | 9/27/2026 | View profile |
| Pharmacy Investors, LLC | ▲ Buy | Option Exercise | 3,863,806 Shares held | 9/27/2026 | View profile |
| Fred Burke See Remarks | ▲ Buy | Option Exercise | 3,438,064 Shares held | 9/27/2026 | View profile |
| Kendall Forbes See Remarks | ▲ Buy | Option Exercise | 1,651,059 Shares held | 9/27/2026 | View profile |
| Cardinal Equity Fund, L.P. | ▲ Buy | Option Exercise | 1,287,237 Shares held | 9/27/2026 | View profile |
| John Ackerman | ▲ Buy | Option Exercise | 1,287,237 Shares held | 9/27/2026 | View profile |
| David K. Morris See Remarks | ▲ Buy | Option Exercise | 896,341 Shares held | 9/27/2026 | View profile |
| Tuch Jeffrey See Remarks | ▲ Buy | Option Exercise | 231,847 Shares held | 9/27/2026 | View profile |
| Martin David Norman See Remarks | ▲ Buy | Option Exercise | 140,905 Shares held | 9/27/2026 | View profile |
| Mudd William Franklin See Remarks | ▲ Buy | Option Exercise | 136,747 Shares held | 9/27/2026 | View profile |
| Eakins Richard Senior Vice President, Sales | ▲ Buy | Option Exercise | 134,930 Shares held | 9/27/2026 | View profile |
| Towns Douglas See Remarks | ▲ Buy | Option Exercise | 113,006 Shares held | 9/27/2026 | View profile |
| Weir Robert See Remarks | ▲ Buy | Option Exercise | 103,333 Shares held | 9/27/2026 | View profile |
| Crisafulli Chris See Remarks | ▲ Buy | Option Exercise | 53,057 Shares held | 9/27/2026 | View profile |
| Steven D. Cosler Director | ▲ Buy | Grant | 29,012 Shares held | 5/5/2026 | View profile |
| Mary Sue Patchett EVP - Chief Operating Officer | ▲ Buy | Grant | 15,071 Shares held | 5/5/2026 | View profile |
| Randall J. Lewis | ▲ Buy | Grant | 15,071 Shares held | 5/5/2026 | View profile |
Transaction History
| Mudd William Franklin | ▲ Buy | Option Exercise | 38,282 | — | 9/27/2026 |
| Weir Robert | ▲ Buy | Option Exercise | 23,450 | — | 9/27/2026 |
| John Ackerman | ▲ Buy | Option Exercise | 1,413,939 | — | 9/27/2026 |
| John Ackerman | ▲ Buy | Option Exercise | 471,057 | — | 9/27/2026 |
| Thomas J. Salentine Jr. | ▲ Buy | Option Exercise | 6,100,175 | — | 9/27/2026 |
| Martin David Norman | ▲ Buy | Option Exercise | 39,865 | — | 9/27/2026 |
| Pharmacy Investors, LLC | ▲ Buy | Option Exercise | 1,413,939 | — | 9/27/2026 |
| Fred Burke | ▲ Buy | Option Exercise | 1,298,825 | — | 9/27/2026 |
| Tuch Jeffrey | ▲ Buy | Option Exercise | 55,578 | — | 9/27/2026 |
| Kendall Forbes | ▲ Buy | Option Exercise | 608,570 | — | 9/27/2026 |
| William E. Bindley | ▲ Buy | Option Exercise | 6,100,175 | — | 9/27/2026 |
| David K. Morris | ▲ Buy | Option Exercise | 641,870 | — | 9/27/2026 |
| Crisafulli Chris | ▲ Buy | Option Exercise | 18,931 | — | 9/27/2026 |
| Eakins Richard | ▲ Buy | Option Exercise | 36,052 | — | 9/27/2026 |
| Cardinal Equity Fund, L.P. | ▲ Buy | Option Exercise | 471,057 | — | 9/27/2026 |
| Bindley Capital Partners I, LLC | ▲ Buy | Option Exercise | 6,100,175 | — | 9/27/2026 |
| Towns Douglas | ▲ Buy | Option Exercise | 23,450 | — | 9/27/2026 |
| Steven D. Cosler | ▲ Buy | Grant | 4,028 | $0 | 5/5/2026 |
| Mary Sue Patchett | ▲ Buy | Grant | 4,028 | $0 | 5/5/2026 |
| Randall J. Lewis | ▲ Buy | Grant | 4,028 | $0 | 5/5/2026 |
| Pharmacy Investors, LLC | ▲ Buy | Option Exercise | 1,413,939 | — | 3/28/2026 |
| William E. Bindley | ▲ Buy | Option Exercise | 6,100,175 | — | 3/28/2026 |
| Kendall Forbes | ▲ Buy | Option Exercise | 608,570 | — | 3/28/2026 |
| Cardinal Equity Fund, L.P. | ▲ Buy | Option Exercise | 471,057 | — | 3/28/2026 |
| David K. Morris | ▲ Buy | Option Exercise | 641,869 | — | 3/28/2026 |
| Bindley Capital Partners I, LLC | ▲ Buy | Option Exercise | 6,100,175 | — | 3/28/2026 |
| Thomas J. Salentine Jr. | ▲ Buy | Option Exercise | 6,100,175 | — | 3/28/2026 |
| John Ackerman | ▲ Buy | Option Exercise | 1,413,939 | — | 3/28/2026 |
| John Ackerman | ▲ Buy | Option Exercise | 471,057 | — | 3/28/2026 |
| Fred Burke | ▲ Buy | Option Exercise | 1,298,826 | — | 3/28/2026 |
| Pharmacy Investors, LLC | ▼ Sell | Open Market | 827,636 | $24.6M | 3/20/2026 |
| David K. Morris | ▼ Sell | Open Market | 187,855 | $5.6M | 3/20/2026 |
| Fred Burke | ▼ Sell | Open Market | 671,432 | $19.9M | 3/20/2026 |
| Kendall Forbes | ▼ Sell | Open Market | 346,672 | $10.3M | 3/20/2026 |
| Cardinal Equity Fund, L.P. | ▼ Sell | Open Market | 275,728 | $8.2M | 3/20/2026 |
| Thomas J. Salentine Jr. | ▼ Sell | Open Market | 3,570,677 | $106.0M | 3/20/2026 |
| Bindley Capital Partners I, LLC | ▼ Sell | Open Market | 3,570,677 | $106.0M | 3/20/2026 |
| John Ackerman | ▼ Sell | Open Market | 827,636 | $24.6M | 3/20/2026 |
| John Ackerman | ▼ Sell | Open Market | 275,728 | $8.2M | 3/20/2026 |
| William E. Bindley | ▼ Sell | Open Market | 3,570,677 | $106.0M | 3/20/2026 |
| Kendall Forbes | ▲ Buy | Grant | 8,952 | $0 | 3/1/2026 |
| David K. Morris | ▲ Buy | Grant | 8,952 | $0 | 3/1/2026 |
| Fred Burke | ▼ Sell | Gift | 200,000 | $0 | 12/4/2025 |
| Kendall Forbes | ▼ Sell | Gift | 21,500 | $0 | 12/4/2025 |
| Steven D. Cosler | ▲ Buy | Open Market | 3,370 | $100K | 12/3/2025 |
| Cardinal Equity Fund, L.P. | ▲ Buy | Option Exercise | 471,057 | — | 9/27/2025 |
| Bindley Capital Partners I, LLC | ▲ Buy | Option Exercise | 6,100,176 | — | 9/27/2025 |
| Thomas J. Salentine Jr. | ▲ Buy | Option Exercise | 6,100,176 | — | 9/27/2025 |
| David K. Morris | ▲ Buy | Option Exercise | 641,869 | — | 9/27/2025 |
| William E. Bindley | ▲ Buy | Option Exercise | 6,100,176 | — | 9/27/2025 |
| Pharmacy Investors, LLC | ▲ Buy | Option Exercise | 1,413,940 | — | 9/27/2025 |
| Fred Burke | ▲ Buy | Option Exercise | 1,298,826 | — | 9/27/2025 |
| John Ackerman | ▲ Buy | Option Exercise | 1,413,940 | — | 9/27/2025 |
| John Ackerman | ▲ Buy | Option Exercise | 471,057 | — | 9/27/2025 |
| Kendall Forbes | ▲ Buy | Option Exercise | 608,570 | — | 9/27/2025 |
| Cardinal Equity Fund, L.P. | ▼ Sell | Open Market | 50,305 | $1.0M | 5/28/2025 |
| Pharmacy Investors, LLC | ▼ Sell | Open Market | 150,998 | $3.0M | 5/28/2025 |
| William E. Bindley | ▼ Sell | Open Market | 651,454 | $13.1M | 5/28/2025 |
| Thomas J. Salentine Jr. | ▼ Sell | Open Market | 651,454 | $13.1M | 5/28/2025 |
| David K. Morris | ▼ Sell | Open Market | 68,547 | $1.4M | 5/28/2025 |
| John Ackerman | ▼ Sell | Open Market | 50,305 | $1.0M | 5/28/2025 |
| John Ackerman | ▼ Sell | Open Market | 150,998 | $3.0M | 5/28/2025 |
| Kendall Forbes | ▼ Sell | Open Market | 64,991 | $1.3M | 5/28/2025 |
| Fred Burke | ▼ Sell | Open Market | 138,705 | $2.8M | 5/28/2025 |
| Bindley Capital Partners I, LLC | ▼ Sell | Open Market | 651,454 | $13.1M | 5/28/2025 |
| Pharmacy Investors, LLC | ▼ Sell | Open Market | 813,318 | $16.4M | 5/27/2025 |
| William E. Bindley | ▼ Sell | Open Market | 3,508,905 | $70.7M | 5/27/2025 |
| Thomas J. Salentine Jr. | ▼ Sell | Open Market | 3,508,905 | $70.7M | 5/27/2025 |
| John Ackerman | ▼ Sell | Open Market | 813,318 | $16.4M | 5/27/2025 |
| Fred Burke | ▼ Sell | Open Market | 747,102 | $15.1M | 5/27/2025 |
| John Ackerman | ▼ Sell | Open Market | 270,958 | $5.5M | 5/27/2025 |
| Kendall Forbes | ▼ Sell | Open Market | 350,058 | $7.1M | 5/27/2025 |
| David K. Morris | ▼ Sell | Open Market | 369,212 | $7.4M | 5/27/2025 |
| Bindley Capital Partners I, LLC | ▼ Sell | Open Market | 3,508,905 | $70.7M | 5/27/2025 |
| Cardinal Equity Fund, L.P. | ▼ Sell | Open Market | 270,958 | $5.5M | 5/27/2025 |
| Steven D. Cosler | ▲ Buy | Grant | 3,901 | $0 | 5/9/2025 |
| Mary Sue Patchett | ▲ Buy | Grant | 3,901 | $0 | 5/9/2025 |
| Randall J. Lewis | ▲ Buy | Grant | 3,901 | $0 | 5/9/2025 |
| William E. Bindley | ▲ Buy | Option Exercise | 6,100,176 | — | 3/28/2025 |
| David K. Morris | ▲ Buy | Option Exercise | 641,869 | — | 3/28/2025 |
| John Ackerman | ▲ Buy | Option Exercise | 1,413,940 | — | 3/28/2025 |
| John Ackerman | ▲ Buy | Option Exercise | 471,057 | — | 3/28/2025 |
| Kendall Forbes | ▲ Buy | Option Exercise | 608,570 | — | 3/28/2025 |
| Thomas J. Salentine Jr. | ▲ Buy | Option Exercise | 6,100,176 | — | 3/28/2025 |
| Fred Burke | ▲ Buy | Option Exercise | 1,298,826 | — | 3/28/2025 |
| Kendall Forbes | ▲ Buy | Grant | 10,385 | $0 | 2/5/2025 |
| David K. Morris | ▲ Buy | Grant | 10,385 | $0 | 2/5/2025 |
| Steven D. Cosler | ▲ Buy | Open Market | 7,000 | $149K | 11/19/2024 |
| Thomas J. Salentine Jr. | ▲ Buy | Open Market | 35,714 | $500K | 9/27/2024 |
| Mary Sue Patchett | ▲ Buy | Open Market | 3,571 | $50K | 9/27/2024 |
| Mary Sue Patchett | ▲ Buy | Grant | 3,571 | $0 | 9/27/2024 |
| Randall J. Lewis | ▲ Buy | Open Market | 3,571 | $50K | 9/27/2024 |
| Randall J. Lewis | ▲ Buy | Grant | 3,571 | $0 | 9/27/2024 |
| Steven D. Cosler | ▲ Buy | Open Market | 7,142 | $100K | 9/27/2024 |
| Steven D. Cosler | ▲ Buy | Grant | 3,571 | $0 | 9/27/2024 |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 12, 2026
Guardian Pharmacy Services Q2 2026 Earnings Call Highlights
Guardian Pharmacy Services held its Q2 2026 earnings conference call, reviewing the quarter’s financial results and outlook. Management addressed performance metrics and future expectations, offering insight for investors. The discussion comes as the stock trades near its recent support level of $40.33, with an RSI around 40, indicating modest momentum.
Guardian Pharmacy Services Q2 2026 Earnings Call Highlights. Guardian Pharmacy Services held its Q2 2026 earnings conference call, reviewing the quarter’s financial results and outlook. Management addressed performance metrics and future expectations, offering insight for investors. The discussion comes as the stock trades near its recent support level of $40.33, with an RSI around 40, indicating modest momentum.